Thousands got Exactech knee or hip replacements. Then, patients say, the parts began to fail.

Ex­sci­en­tia an­nounced a $40 mil­lion cost-sav­ing pro­gram on Tues­day that will lead to lay­offs af­fect­ing 20% to 25% of the com­pa­ny’s work­ers. The move, dis­closed

The future of psychedelic research was dealt its biggest setback in years after the FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder